36372-62-0Relevant academic research and scientific papers
Tariquidar-related triazoles as potent, selective and stable inhibitors of ABCG2 (BCRP)
Antoni, Frauke,Bauer, Stefanie,Bause, Manuel,Bernhardt, Günther,Buschauer, Armin,Jackson, Scott M.,K?nig, Burkhard,Locher, Kaspar P.,Manolaridis, Ioannis,Scholler, Matthias,Stark, Simone A.
supporting information, (2020/02/26)
Tariquidar derivatives have been described as potent and selective ABCG2 inhibitors. However, their susceptibility to hydrolysis limits their applicability. The current study comprises the synthesis and characterization of novel tariquidar-related inhibit
Transformations of N-(2-acylaryl)benzamides and their analogs under the Camps cyclization conditions
Mochalov,Fedotov,Trofimova,Zefirov
, p. 956 - 969 (2016/09/04)
N-(2-Acylaryl)benzamides and analogous N-substituted furan-2-, thiophene-2-, and cyclopropane-carboxamides in the systems EtONa–EtOH, EtONa–THF, and t-BuOK–t-BuOH undergo Camps cyclization to 2-aryl-, 2-hetaryl-, and 2-cyclopropylquinolin-4(1H)-ones with
Design of new reaction conditions for the Sugasawa reaction based on mechanistic insights
Prasad, Kapa,Lee, George T.,Chaudhary, Apurva,Girgis, Michael J.,Streemke, James W.,Repic, Oljan
, p. 723 - 732 (2013/09/05)
A process to prepare 2-propionyl-4-bromoaniline by ortho acylation of 4-bromoaniline under Sugasawa conditions was developed. Upon scale-up in a pilot plant, the process gave lower yields than in the laboratory in four out of five plant runs. Analysis of
Synthesis and antitumor activity of 20(S)-camptothecin derivatives. A-ring-substituted 7-ethylcamptothecins and their E-ring-modified water-soluble derivatives
Yaegashi,Sawada,Nagata,Furuta,Yokokura,Miyasaka
, p. 2518 - 2525 (2007/10/02)
Twenty-six novel A-ring-modified 7-ethylcamptothecins (6) were synthesized by Friedlander's condensation of the chiral tricyclic ketone (5) with aminopropiophenones (4). The compounds substituted with fluorine at the 11 position showed strong cytotoxicity
Camptothecin derivatives
-
, (2008/06/13)
New campotothecin derivatives and a process for preparing same are disclosed, which are represented by the general formula: STR1 wherein R1 represents a lower alkyl group, R2 represents a hydrogen atom or an amino, hydroxyl, lower acylamino or lower alkoxy group, R3 represents a hydrogen or halogen atom or a lower alkyl, hydroxyl, lower alkoxy, nitro, amino, cyano or di(lower alkyl)amino group, R4 represents a hydrogen or halogen atom or a lower alkyl, hydroxyl, lower alkoxy, lower alkylthio, amino, cyano or di(lower alkyl)amino group, and R5 represents a hydrogen or halogen atom or a hydroxyl or lower alkoxy group, with the proviso that all of the R2, R3, R4 and R5 substituents should not be a hydrogen atom and also that if any one of the R2, R3, R4 and R5 is a hydroxyl or lower alkoxy group, all of the other three substituents should not be a hydrogen atom.
